Your session is about to expire
← Back to Search
Physician-focused Behavioral Intervention for Prostate Cancer Imaging
N/A
Waitlist Available
Led By Danil V Makarov, MD MHS
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 4 years
Awards & highlights
Study Summary
This trial is testing whether a multi-disciplinary, physician-focused behavioral intervention can improve facility-level guideline-concordant utilization of prostate cancer staging imaging.
Who is the study for?
This trial is for Urology Chiefs, attending urologists, Physician Assistants, and Nurse Practitioners at the VA who've treated at least 5 men with new prostate cancer in the last 6 months. It's not for residents or those over 85 years old, without certain medical data, a history of other cancers, or patients diagnosed post-mortem.Check my eligibility
What is being tested?
The study tests if a multi-part intervention aimed at doctors can make prostate cancer imaging more guideline-concordant. Methods include Clinical Order Checks to guide decisions, Academic Detailing for education on best practices, and Audit and Feedback to review physician performance.See study design
What are the potential side effects?
Since this trial focuses on physician behavior rather than direct patient treatments, it does not involve typical medication side effects. However, there may be indirect effects on patient care based on changes in imaging practices.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through study completion, an average of 4 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 4 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Malignant Neoplasms
Facility-level inappropriate prostate cancer imaging rates
Secondary outcome measures
Individual-level appropriate prostate cancer imaging rates
Individual-level inappropriate prostate cancer imaging rates
Net cost of implementation of the behavioral intervention
+1 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment3 Interventions
The intervention is comprised of three components: 1) Clinical Order Check, 2) Academic Detailing, and 3) Audit and Feedback.
Group II: ControlActive Control1 Intervention
No intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Academic Detailing
2003
Completed Phase 4
~80010
Audit and Feedback
2016
N/A
~85550
Find a Location
Who is running the clinical trial?
VA Office of Research and DevelopmentLead Sponsor
1,620 Previous Clinical Trials
3,323,348 Total Patients Enrolled
14 Trials studying Prostate Cancer
8,727 Patients Enrolled for Prostate Cancer
Danil V Makarov, MD MHSPrincipal InvestigatorManhattan Campus of the VA NY Harbor Healthcare System, New York, NY
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am over 85 years old.I lack data on my PSA, clinical stage, or Gleason score.I have never had cancer before.I am a PA or NP who has cared for at least 5 men with new prostate cancer cases in the last 6 months.My gender or race does not affect my eligibility.
Research Study Groups:
This trial has the following groups:- Group 1: Intervention
- Group 2: Control
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger